Open AccessOccasional Diagnosis of Acute Myeloid Leukemia Due To SARS-COV 2 Infection
Author(s) -
Leonardo Ribeiro,
João Manuel Pereira,
Carine Melo,
Claudia Lopes,
Juliana Cardoso Alves,
Gustavo Guzzi,
Marcelo Pinto,
M. Carneiro De Moura.
Publication year - 2021
Publication title -
residência pediátrica
Language(s) - English
Resource type - Journals
ISSN - 2236-6814
DOI - 10.25060/residpediatr-2021.v11n1-439
Subject(s) - medicine , nose , myeloid leukemia , pandemic , intensive care medicine , pediatrics , mitoxantrone , disease , infectious disease (medical specialty) , surgery , covid-19 , chemotherapy
OBJECTIVES: To describe a patient with SARS-CoV-2, who was diagnosed with acute myeloid leukemia M3. CASE REPORT: Patient, 12 years old, female, started with bruises in the lower limbs and pain in the left leg; however, in the face of the current pandemic, the patient was delayed in seeking medical help due to fear of contamination by SARS-CoV-2. After 1 month she presented fever, runny nose, and cacosmia. She sought medical assistance for apprehension of being infected with the new coronavirus due to the fact that the mother is a health professional. The child was admitted to the emergency room, with leukopenia, thrombocy-topenia, and positive COVID-19. She remained hospitalized for 8 days in the hospital of entry. Initially, it was suspected of idiopathic thrombocytopenic purpura; however, with the evolution of the case it suggested the diagnostic possibility of oncological disease. She was transferred to a specialty hospital, where she was diagnosed with acute myeloid leukemia subtype M3. After diagnosis, tretinoin associated with platelet transfusion and cryoprecipitate and subsequent chemotherapy with idarubicin was started. CONCLUSIONS: It can be analyzed that, in the face of the SARS-CoV-2 pandemic, many diseases can arise together with the viral infectious condition. On the other hand, we cannot fail to consider that in view of the current epidemiological and behavioral changes, the diagnosis, treatment, and prognosis of previously existing diseases that, in due course, coexist with SARS-CoV-2 infection, can be postponed, due to the fear and due to the difficulty of accessing the health system.